Market Overview:
The global cervical cancer diagnostic testing devices market is expected to grow at a CAGR of 7.5% during the forecast period from 2018 to 2030. The market growth can be attributed to the increasing incidence of cervical cancer, rising awareness about early diagnosis and treatment of cervical cancer, and technological advancements in diagnostic testing devices. Based on type, the global cervical cancer diagnostic testing devices market is segmented into cytopathological method and molecular method. The cytopathological method segment dominates the global market due to its low cost and easy availability. However, the molecular method segment is expected to grow at a higher CAGR during the forecast period owing to its high accuracy rate and growing demand for personalized medicine. Based on application, the global cervical cancer diagnostic testing devices market is divided into homecare, clinics, and hospitals segments. The homecare segment dominates this market due to rising preference for home-based care among patients suffering from various diseases including cervical cancer. However, clinics are projected witness highest growth rate during 2018-2030 owing growing number of private clinics across different regions worldwide coupled with increasing healthcare expenditure by individuals/governments in developed countries such as UAS., Canada.
Product Definition:
Cervical Cancer Diagnostic Testing Devices are used to diagnose cervical cancer. They include a Pap test, which is a procedure in which cells are collected from the cervix and examined under a microscope, and an HPV test, which detects the presence of human papillomavirus (HPV), the virus that causes cervical cancer.
Cytopathological Method:
The global cytopathological method, it's usage and growth factor in cervical cancer diagnostic testing devices market is expected to grow at a significant rate during the forecast period. The factors that propel the growth of this market are increasing prevalence of cervical cancer and growing geriatric population base.
Molecular Method:
The molecular method is used for the diagnosis of cervical cancer. It's major application includes detection of gene mutations that cause abnormal cell growth. The test also helps in determining the stage of disease, which further guides in deciding appropriate treatment to be administered to the patient.
Molecular diagnostics (MDx) are tests that provide information about a specific gene mutation or an abnormal cell growth pattern and help determine if a person is susceptible to certain diseases or not.
Application Insights:
The market is segmented by application into homecare, clinics, and hospitals. The clinics segment dominated the global market in 2017 owing to factors such as increasing awareness about the benefits of early diagnosis and rising prevalence of cancer across various regions. According to WHO, around 1 in 5 women are estimated to develop invasive cervical cancer during their lifetime which accounts for over 2 million cases per year globally. Thus a major factor contributing towards growth of this segment is high incidence rate of cervical cancer coupled with growing awareness among individuals regarding availability of diagnostic tests at an early stage.
Regional Analysis:
North America dominated the global market in 2017. This can be attributed to the presence of key players, high disposable income, and availability of advanced healthcare facilities. Moreover, increasing government initiatives for cancer screening programs is also expected to drive regional growth over the forecast period. For instance, as per a CDC study published in 2016’s issue of MMWR; National Cancer Institute (NCI) estimated that more than 1 million women between ages 25 and 34 had been diagnosed with invasive cervical cancer in North America alone since its inception in 1953 until 2015.
In Asia Pacific market; however many countries such as Japan are already occupied by technologically advanced systems which have been approved by U.
Growth Factors:
- Increasing incidence of cervical cancer: The incidence of cervical cancer is increasing at a fast pace across the globe. This is primarily attributed to the changing lifestyle and growing population. This, in turn, is expected to boost the demand for cervical cancer diagnostic testing devices over the forecast period.
- Technological advancements: The technological advancements in diagnostic testing devices are helping healthcare professionals to detect early-stage cervical cancers. This is aiding in better treatment outcomes and reducing mortality rates associated with this disease. Thus, technological advancements are expected to be one of the key growth drivers for this market during the forecast period.
- Growing awareness about early detection: There is a growing awareness among women about the importance of early detection of cervical cancer through screening tests such as Pap smear test and HPV DNA test etcetera .This is resulting in an increase in demand for these diagnostic testing devices worldwide thereby propelling market growth during the forecast period .
Scope Of The Report
Report Attributes
Report Details
Report Title
Cervical Cancer Diagnostic Testing Devices Market Research Report
By Type
Cytopathological Method, Molecular Method
By Application
Homecare, Clinics, Hospitals
By Companies
Abbott Molecular, Becton, Dickinson & Company, Hologic, Qiagen, Quest Diagnostics, Delphi Bioscience, DAAN Gene, Roche Molecular Diagnostics, Arbor Vita, BioMerieux, Cepheid, OncoHealth, Solopap International, Cervia Diagnostics, Trovagene
Regions Covered
North America, Europe, APAC, Latin America, MEA
Base Year
2021
Historical Year
2019 to 2020 (Data from 2010 can be provided as per availability)
Forecast Year
2030
Number of Pages
157
Number of Tables & Figures
110
Customization Available
Yes, the report can be customized as per your need.
Global Cervical Cancer Diagnostic Testing Devices Market Report Segments:
The global Cervical Cancer Diagnostic Testing Devices market is segmented on the basis of:
Types
Cytopathological Method, Molecular Method
The product segment provides information about the market share of each product and the respective CAGR during the forecast period. It lays out information about the product pricing parameters, trends, and profits that provides in-depth insights of the market. Furthermore, it discusses latest product developments & innovation in the market.
Applications
Homecare, Clinics, Hospitals
The application segment fragments various applications of the product and provides information on the market share and growth rate of each application segment. It discusses the potential future applications of the products and driving and restraining factors of each application segment.
Some of the companies that are profiled in this report are:
- Abbott Molecular
- Becton
- Dickinson & Company
- Hologic
- Qiagen
- Quest Diagnostics
- Delphi Bioscience
- DAAN Gene
- Roche Molecular Diagnostics
- Arbor Vita
- BioMerieux
- Cepheid
- OncoHealth
- Solopap International
- Cervia Diagnostics
- Trovagene
Highlights of The Cervical Cancer Diagnostic Testing Devices Market Report:
- The market structure and projections for the coming years.
- Drivers, restraints, opportunities, and current trends of market.
- Historical data and forecast.
- Estimations for the forecast period 2030.
- Developments and trends in the market.
- By Type:
- Cytopathological Method
- Molecular Method
- By Application:
- Homecare
- Clinics
- Hospitals
- Market scenario by region, sub-region, and country.
- Market share of the market players, company profiles, product specifications, SWOT analysis, and competitive landscape.
- Analysis regarding upstream raw materials, downstream demand, and current market dynamics.
- Government Policies, Macro & Micro economic factors are also included in the report.
We have studied the Cervical Cancer Diagnostic Testing Devices Market in 360 degrees via. both primary & secondary research methodologies. This helped us in building an understanding of the current market dynamics, supply-demand gap, pricing trends, product preferences, consumer patterns & so on. The findings were further validated through primary research with industry experts & opinion leaders across countries. The data is further compiled & validated through various market estimation & data validation methodologies. Further, we also have our in-house data forecasting model to predict market growth up to 2030.
Regional Analysis
- North America
- Europe
- Asia Pacific
- Middle East & Africa
- Latin America
Note: A country of choice can be added in the report at no extra cost. If more than one country needs to be added, the research quote will vary accordingly.
The geographical analysis part of the report provides information about the product sales in terms of volume and revenue in regions. It lays out potential opportunities for the new entrants, emerging players, and major players in the region. The regional analysis is done after considering the socio-economic factors and government regulations of the countries in the regions.
How you may use our products:
- Correctly Positioning New Products
- Market Entry Strategies
- Business Expansion Strategies
- Consumer Insights
- Understanding Competition Scenario
- Product & Brand Management
- Channel & Customer Management
- Identifying Appropriate Advertising Appeals
8 Reasons to Buy This Report
- Includes a Chapter on the Impact of COVID-19 Pandemic On the Market
- Report Prepared After Conducting Interviews with Industry Experts & Top Designates of the Companies in the Market
- Implemented Robust Methodology to Prepare the Report
- Includes Graphs, Statistics, Flowcharts, and Infographics to Save Time
- Industry Growth Insights Provides 24/5 Assistance Regarding the Doubts in the Report
- Provides Information About the Top-winning Strategies Implemented by Industry Players.
- In-depth Insights On the Market Drivers, Restraints, Opportunities, and Threats
- Customization of the Report Available
Frequently Asked Questions?
Cervical cancer diagnostic testing devices are medical equipment that are used to diagnose cervical cancer. These devices can include a Pap test, HPV test, or colposcopy.
Some of the major players in the cervical cancer diagnostic testing devices market are Abbott Molecular, Becton, Dickinson & Company, Hologic, Qiagen, Quest Diagnostics, Delphi Bioscience, DAAN Gene, Roche Molecular Diagnostics, Arbor Vita, BioMerieux, Cepheid, OncoHealth, Solopap International, Cervia Diagnostics, Trovagene.
The cervical cancer diagnostic testing devices market is expected to register a CAGR of 7.5%.
Chapter 1 Executive Summary
Chapter 2 Assumptions and Acronyms Used
Chapter 3 Research Methodology
Chapter 4 Cervical Cancer Diagnostic Testing Devices Market Overview
4.1 Introduction
4.1.1 Market Taxonomy
4.1.2 Market Definition
4.1.3 Macro-Economic Factors Impacting the Market Growth
4.2 Cervical Cancer Diagnostic Testing Devices Market Dynamics
4.2.1 Market Drivers
4.2.2 Market Restraints
4.2.3 Market Opportunity
4.3 Cervical Cancer Diagnostic Testing Devices Market - Supply Chain Analysis
4.3.1 List of Key Suppliers
4.3.2 List of Key Distributors
4.3.3 List of Key Consumers
4.4 Key Forces Shaping the Cervical Cancer Diagnostic Testing Devices Market
4.4.1 Bargaining Power of Suppliers
4.4.2 Bargaining Power of Buyers
4.4.3 Threat of Substitution
4.4.4 Threat of New Entrants
4.4.5 Competitive Rivalry
4.5 Global Cervical Cancer Diagnostic Testing Devices Market Size & Forecast, 2018-2028
4.5.1 Cervical Cancer Diagnostic Testing Devices Market Size and Y-o-Y Growth
4.5.2 Cervical Cancer Diagnostic Testing Devices Market Absolute $ Opportunity
Chapter 5 Global Cervical Cancer Diagnostic Testing Devices Market Analysis and Forecast by Type
5.1 Introduction
5.1.1 Key Market Trends & Growth Opportunities by Type
5.1.2 Basis Point Share (BPS) Analysis by Type
5.1.3 Absolute $ Opportunity Assessment by Type
5.2 Cervical Cancer Diagnostic Testing Devices Market Size Forecast by Type
5.2.1 Cytopathological Method
5.2.2 Molecular Method
5.3 Market Attractiveness Analysis by Type
Chapter 6 Global Cervical Cancer Diagnostic Testing Devices Market Analysis and Forecast by Applications
6.1 Introduction
6.1.1 Key Market Trends & Growth Opportunities by Applications
6.1.2 Basis Point Share (BPS) Analysis by Applications
6.1.3 Absolute $ Opportunity Assessment by Applications
6.2 Cervical Cancer Diagnostic Testing Devices Market Size Forecast by Applications
6.2.1 Homecare
6.2.2 Clinics
6.2.3 Hospitals
6.3 Market Attractiveness Analysis by Applications
Chapter 7 Global Cervical Cancer Diagnostic Testing Devices Market Analysis and Forecast by Region
7.1 Introduction
7.1.1 Key Market Trends & Growth Opportunities by Region
7.1.2 Basis Point Share (BPS) Analysis by Region
7.1.3 Absolute $ Opportunity Assessment by Region
7.2 Cervical Cancer Diagnostic Testing Devices Market Size Forecast by Region
7.2.1 North America
7.2.2 Europe
7.2.3 Asia Pacific
7.2.4 Latin America
7.2.5 Middle East & Africa (MEA)
7.3 Market Attractiveness Analysis by Region
Chapter 8 Coronavirus Disease (COVID-19) Impact
8.1 Introduction
8.2 Current & Future Impact Analysis
8.3 Economic Impact Analysis
8.4 Government Policies
8.5 Investment Scenario
Chapter 9 North America Cervical Cancer Diagnostic Testing Devices Analysis and Forecast
9.1 Introduction
9.2 North America Cervical Cancer Diagnostic Testing Devices Market Size Forecast by Country
9.2.1 U.S.
9.2.2 Canada
9.3 Basis Point Share (BPS) Analysis by Country
9.4 Absolute $ Opportunity Assessment by Country
9.5 Market Attractiveness Analysis by Country
9.6 North America Cervical Cancer Diagnostic Testing Devices Market Size Forecast by Type
9.6.1 Cytopathological Method
9.6.2 Molecular Method
9.7 Basis Point Share (BPS) Analysis by Type
9.8 Absolute $ Opportunity Assessment by Type
9.9 Market Attractiveness Analysis by Type
9.10 North America Cervical Cancer Diagnostic Testing Devices Market Size Forecast by Applications
9.10.1 Homecare
9.10.2 Clinics
9.10.3 Hospitals
9.11 Basis Point Share (BPS) Analysis by Applications
9.12 Absolute $ Opportunity Assessment by Applications
9.13 Market Attractiveness Analysis by Applications
Chapter 10 Europe Cervical Cancer Diagnostic Testing Devices Analysis and Forecast
10.1 Introduction
10.2 Europe Cervical Cancer Diagnostic Testing Devices Market Size Forecast by Country
10.2.1 Germany
10.2.2 France
10.2.3 Italy
10.2.4 U.K.
10.2.5 Spain
10.2.6 Russia
10.2.7 Rest of Europe
10.3 Basis Point Share (BPS) Analysis by Country
10.4 Absolute $ Opportunity Assessment by Country
10.5 Market Attractiveness Analysis by Country
10.6 Europe Cervical Cancer Diagnostic Testing Devices Market Size Forecast by Type
10.6.1 Cytopathological Method
10.6.2 Molecular Method
10.7 Basis Point Share (BPS) Analysis by Type
10.8 Absolute $ Opportunity Assessment by Type
10.9 Market Attractiveness Analysis by Type
10.10 Europe Cervical Cancer Diagnostic Testing Devices Market Size Forecast by Applications
10.10.1 Homecare
10.10.2 Clinics
10.10.3 Hospitals
10.11 Basis Point Share (BPS) Analysis by Applications
10.12 Absolute $ Opportunity Assessment by Applications
10.13 Market Attractiveness Analysis by Applications
Chapter 11 Asia Pacific Cervical Cancer Diagnostic Testing Devices Analysis and Forecast
11.1 Introduction
11.2 Asia Pacific Cervical Cancer Diagnostic Testing Devices Market Size Forecast by Country
11.2.1 China
11.2.2 Japan
11.2.3 South Korea
11.2.4 India
11.2.5 Australia
11.2.6 South East Asia (SEA)
11.2.7 Rest of Asia Pacific (APAC)
11.3 Basis Point Share (BPS) Analysis by Country
11.4 Absolute $ Opportunity Assessment by Country
11.5 Market Attractiveness Analysis by Country
11.6 Asia Pacific Cervical Cancer Diagnostic Testing Devices Market Size Forecast by Type
11.6.1 Cytopathological Method
11.6.2 Molecular Method
11.7 Basis Point Share (BPS) Analysis by Type
11.8 Absolute $ Opportunity Assessment by Type
11.9 Market Attractiveness Analysis by Type
11.10 Asia Pacific Cervical Cancer Diagnostic Testing Devices Market Size Forecast by Applications
11.10.1 Homecare
11.10.2 Clinics
11.10.3 Hospitals
11.11 Basis Point Share (BPS) Analysis by Applications
11.12 Absolute $ Opportunity Assessment by Applications
11.13 Market Attractiveness Analysis by Applications
Chapter 12 Latin America Cervical Cancer Diagnostic Testing Devices Analysis and Forecast
12.1 Introduction
12.2 Latin America Cervical Cancer Diagnostic Testing Devices Market Size Forecast by Country
12.2.1 Brazil
12.2.2 Mexico
12.2.3 Rest of Latin America (LATAM)
12.3 Basis Point Share (BPS) Analysis by Country
12.4 Absolute $ Opportunity Assessment by Country
12.5 Market Attractiveness Analysis by Country
12.6 Latin America Cervical Cancer Diagnostic Testing Devices Market Size Forecast by Type
12.6.1 Cytopathological Method
12.6.2 Molecular Method
12.7 Basis Point Share (BPS) Analysis by Type
12.8 Absolute $ Opportunity Assessment by Type
12.9 Market Attractiveness Analysis by Type
12.10 Latin America Cervical Cancer Diagnostic Testing Devices Market Size Forecast by Applications
12.10.1 Homecare
12.10.2 Clinics
12.10.3 Hospitals
12.11 Basis Point Share (BPS) Analysis by Applications
12.12 Absolute $ Opportunity Assessment by Applications
12.13 Market Attractiveness Analysis by Applications
Chapter 13 Middle East & Africa (MEA) Cervical Cancer Diagnostic Testing Devices Analysis and Forecast
13.1 Introduction
13.2 Middle East & Africa (MEA) Cervical Cancer Diagnostic Testing Devices Market Size Forecast by Country
13.2.1 Saudi Arabia
13.2.2 South Africa
13.2.3 UAE
13.2.4 Rest of Middle East & Africa (MEA)
13.3 Basis Point Share (BPS) Analysis by Country
13.4 Absolute $ Opportunity Assessment by Country
13.5 Market Attractiveness Analysis by Country
13.6 Middle East & Africa (MEA) Cervical Cancer Diagnostic Testing Devices Market Size Forecast by Type
13.6.1 Cytopathological Method
13.6.2 Molecular Method
13.7 Basis Point Share (BPS) Analysis by Type
13.8 Absolute $ Opportunity Assessment by Type
13.9 Market Attractiveness Analysis by Type
13.10 Middle East & Africa (MEA) Cervical Cancer Diagnostic Testing Devices Market Size Forecast by Applications
13.10.1 Homecare
13.10.2 Clinics
13.10.3 Hospitals
13.11 Basis Point Share (BPS) Analysis by Applications
13.12 Absolute $ Opportunity Assessment by Applications
13.13 Market Attractiveness Analysis by Applications
Chapter 14 Competition Landscape
14.1 Cervical Cancer Diagnostic Testing Devices Market: Competitive Dashboard
14.2 Global Cervical Cancer Diagnostic Testing Devices Market: Market Share Analysis, 2019
14.3 Company Profiles (Details – Overview, Financials, Developments, Strategy)
14.3.1 Abbott Molecular
14.3.2 Becton
14.3.3 Dickinson & Company
14.3.4 Hologic
14.3.5 Qiagen
14.3.6 Quest Diagnostics
14.3.7 Delphi Bioscience
14.3.8 DAAN Gene
14.3.9 Roche Molecular Diagnostics
14.3.10 Arbor Vita
14.3.11 BioMerieux
14.3.12 Cepheid
14.3.13 OncoHealth
14.3.14 Solopap International
14.3.15 Cervia Diagnostics
14.3.16 Trovagene
